Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Vogel

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Developments in Biological Standardization|April 29, 1998
Adjuvants in perspectiveF R Vogel
International Journal of Immunopharmacology|February 1, 1995
The role of adjuvants in retroviral vaccinesF R Vogel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2000
Improving vaccine performance with adjuvantsF R Vogel
Antibiotics and Chemotherapy|January 1, 1996
Role of adjuvants in HIV vaccine designF R Vogel
Annals of the New York Academy of Sciences|May 31, 1995
Immunologic adjuvants for modern vaccine formulationsF R Vogel
Critical Reviews in Therapeutic Drug Carrier Systems|January 1, 1986
Synthetic immunomodulators and synthetic vaccinesC Leclerc, F R Vogel
Clinical Microbiology Reviews|July 1, 1995
Nucleic acid vaccinesF R Vogel, N Sarver
Pharmaceutical Biotechnology|January 1, 1995
A compendium of vaccine adjuvants and excipientsF R Vogel, M F Powell
Annual Review of Immunology|January 1, 1986
Current status of immunological adjuvantsH S Warren, F R Vogel, L A Chedid
Cellular Immunology|January 1, 1987
Epitopic suppression in synthetic vaccine models: analysis of the effector mechanismsM P Schutze, C Leclerc, F R Vogel, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Developments in Biological Standardization|April 29, 1998
Adjuvants in perspectiveF R Vogel
International Journal of Immunopharmacology|February 1, 1995
The role of adjuvants in retroviral vaccinesF R Vogel
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 30, 2000
Improving vaccine performance with adjuvantsF R Vogel
Antibiotics and Chemotherapy|January 1, 1996
Role of adjuvants in HIV vaccine designF R Vogel
Annals of the New York Academy of Sciences|May 31, 1995
Immunologic adjuvants for modern vaccine formulationsF R Vogel
Critical Reviews in Therapeutic Drug Carrier Systems|January 1, 1986
Synthetic immunomodulators and synthetic vaccinesC Leclerc, F R Vogel
Clinical Microbiology Reviews|July 1, 1995
Nucleic acid vaccinesF R Vogel, N Sarver
Pharmaceutical Biotechnology|January 1, 1995
A compendium of vaccine adjuvants and excipientsF R Vogel, M F Powell
Annual Review of Immunology|January 1, 1986
Current status of immunological adjuvantsH S Warren, F R Vogel, L A Chedid
Cellular Immunology|January 1, 1987
Epitopic suppression in synthetic vaccine models: analysis of the effector mechanismsM P Schutze, C Leclerc, F R Vogel, et al.
Pageof 2